ConductScience.org, home

Paper39198634

Attenuated effector T cells are linked to control of chronic HBV infection.

Heim K and 15 others. Nat Immunol, 2024. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Attenuated effector T cells are linked to control of chronic HBV infection. Papers, record 39198634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39198634

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Attenuated effector T cells are linked to control of chronic HBV infection.
PubMed
Journal
Nat Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
6.03, provisional
iCite
Revised in PubMed
2026-04-22
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heim KKathrin
2Sagarhttps://orcid.org/0000-0002-8657-4704
3Sogukpinar ÖÖzlem
4Llewellyn-Lacey SSian
5Price DADavid Ahttps://orcid.org/0000-0001-9416-2737
6Emmerich FFlorian
7Kraft ARMAnke R Mhttps://orcid.org/0000-0002-9666-0753
8Cornberg MMarkus
9Kielbassa SSophie
10Knolle PPercyhttps://orcid.org/0000-0003-2983-0414
11Wohlleber DDirkhttps://orcid.org/0000-0003-3861-5150
12Bengsch BBertramhttps://orcid.org/0000-0003-2552-740X
13Boettler TTobiashttps://orcid.org/0000-0002-1195-055X
14Neumann-Haefelin CChristophhttps://orcid.org/0000-0001-7351-1387
15Thimme RRoberthttps://orcid.org/0000-0003-1417-4135
16Hofmann MMaikehttps://orcid.org/0000-0001-8410-8833

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B, ChronicMajor topic
Hepatitis B virusMajor topic
CD8-Positive T-LymphocytesMajor topic
Humans
Virus Replication
Transforming Growth Factor beta
Male
Female
Cell Differentiation
Adult
Middle Aged
Signal Transduction

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
TRR 179 project no. 272983813Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
CRC 1160 project no. 256073931Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed
CRC 1479 project no. 441891347Deutsche Forschungsgemeinschaft (German Research Foundation)PubMed

Source PubMed

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112477811CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.J Virol2003https://conductscience.org/library/papers/12477811PubMed
210770795The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.J Exp Med2000https://conductscience.org/library/papers/10770795PubMed
315140968Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.J Virol2004https://conductscience.org/library/papers/15140968PubMed
417287266Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.J Virol2007https://conductscience.org/library/papers/17287266PubMed
518695005Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.J Exp Med2008https://conductscience.org/library/papers/18695005PubMed
625225458Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.J Exp Med2014https://conductscience.org/library/papers/25225458PubMed
727452473Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host.Cell Rep2016https://conductscience.org/library/papers/27452473PubMed
828165481Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.Nat Med2017https://conductscience.org/library/papers/28165481PubMed
933097558TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.Gut2020https://conductscience.org/library/papers/33097558PubMed
1026205583Molecular and cellular insights into T cell exhaustion.Nat Rev Immunol2015https://conductscience.org/library/papers/26205583PubMed
1130676822CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.Annu Rev Immunol2019https://conductscience.org/library/papers/30676822PubMed
1220548953Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.PLoS Pathog2010https://conductscience.org/library/papers/20548953PubMed
1331207605TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.Nature2019https://conductscience.org/library/papers/31207605PubMed
1418809920Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18809920PubMed
1527533016T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.Immunity2016https://conductscience.org/library/papers/27533016PubMed
1630622109Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load.Gut2019https://conductscience.org/library/papers/30622109PubMed
1730580250Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.Gut2019https://conductscience.org/library/papers/30580250PubMed
1837541771Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells.Gut2023https://conductscience.org/library/papers/37541771PubMed
1934702717Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection.Gut2022https://conductscience.org/library/papers/34702717PubMed
2027084039Adaptive immunity in HBV infection.J Hepatol2016https://conductscience.org/library/papers/27084039PubMed

See all 55 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42769860From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.Front Pharmacol2026https://conductscience.org/library/papers/42769860PubMed
42728401ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer.Nat Immunol2026https://conductscience.org/library/papers/42728401PubMed
42713265Immune correlates of outcomes after nucleos(t)ide analogue withdrawal in chronic hepatitis B: direct evidence, mechanistic context, and candidate biomarkers.Front Immunol2026https://conductscience.org/library/papers/42713265PubMed
42638743The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B.Front Immunol2026https://conductscience.org/library/papers/42638743PubMed
42519330From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity.Front Immunol2026https://conductscience.org/library/papers/42519330PubMed
42387268A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection.Aliment Pharmacol Ther2026https://conductscience.org/library/papers/42387268PubMed
42380632New insights into progenitor exhausted T cell populations.Nat Rev Immunol2026https://conductscience.org/library/papers/42380632PubMed
42350969Association between changes in HBsAb levels and hepatic adverse events after HBsAg clearance in non-cirrhotic chronic hepatitis B patients.BMC Infect Dis2026https://conductscience.org/library/papers/42350969PubMed
42315521Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B.Nat Commun2026https://conductscience.org/library/papers/42315521PubMed
42310165Compensatory relationships determine the impact of TGF-β on the humoral immune response to hepatitis B surface antigen.J Immunol2026https://conductscience.org/library/papers/42310165PubMed
42179967An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma.Mol Ther Oncol2026https://conductscience.org/library/papers/42179967PubMed
42050590Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review.Infect Agent Cancer2026https://conductscience.org/library/papers/42050590PubMed
42033764Clonal amplification of peripheral CD4+ and CD8+ T cells is associated with clinical response to checkpoint blockade in chronic hepatitis B.Immunohorizons2026https://conductscience.org/library/papers/42033764PubMed
42009166Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy.JHEP Rep2026https://conductscience.org/library/papers/42009166PubMed
41912891T cell adaptation in chronic infections and tumors.Cell Mol Immunol2026https://conductscience.org/library/papers/41912891PubMed
41899088Heterogeneity Analysis of HBeAg-Positive Chronic Hepatitis B Patients with Ultra-High Viral Load (HBV DNA ≥ 7.0 log10 IU/mL).J Clin Med2026https://conductscience.org/library/papers/41899088PubMed
41863669T-Cell Profiles in HBV Functional Cure and People Living With HIV: Known Knowns, Known Unknowns, and Unknown Unknowns.Curr HIV/AIDS Rep2026https://conductscience.org/library/papers/41863669PubMed
41851274Renaissance of antiviral CD8+ T cell immunity in vaccination and disease.Nat Rev Immunol2026https://conductscience.org/library/papers/41851274PubMed
41704420Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B.JHEP Rep2026https://conductscience.org/library/papers/41704420PubMed
41601689Terminally exhausted CD8+ T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology.Front Immunol2025https://conductscience.org/library/papers/41601689PubMed

See all 38 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39198634

GET https://conductscience.org/api/papers/v1/39198634/references?page=2